论文部分内容阅读
Ⅰ临床方面可疑登革出血热629例中,有278例(44.2%)由血清学血凝抑制试验而证实。在菲律宾诊断登革出血热主要依据是发热、束臂试验阳性及病毒血清学检验。登革出血热病例,只有55%有肝脏肿大,因此,肝脏肿大不能列为诊断标准之一。在登革出血热的病例中,也有23%合并胸积液。血小板计数及红细胞压积读数,对处理登革休克综合征的病人是有帮助的指征,但不能作为诊断试验。Ⅱ度登革出血热病例的处理,主要是给予静脉补液。但当处理Ⅲ度及Ⅳ度登革出血热病例时,除了静
Ⅰ In 629 cases of clinically suspected dengue haemorrhagic fever, 278 (44.2%) were confirmed by serological hemagglutination inhibition test. Dengue hemorrhagic fever diagnosis in the Philippines based on fever, beam arm test positive and viral serological test. Dengue hemorrhagic fever cases, only 55% of liver enlargement, therefore, liver enlargement can not be classified as one of the diagnostic criteria. In the case of dengue haemorrhagic fever, 23% had pleural effusion. Platelet count and hematocrit readings are helpful indicators for treating patients with dengue shock syndrome but can not be used as diagnostic tests. Ⅱ degree dengue hemorrhagic fever cases of treatment, mainly given intravenous rehydration. However, when dealing with Ⅲ degree and Ⅳ degree of dengue haemorrhagic fever cases, in addition to static